PIK3CA and hepatocellular carcinoma: Interestingly, a kinase profiler analysis revealed that CGS 15943 is able to inhibit p110γ (Edling et al., 2014), further supporting the conclusion that targeting this PI3K isoform may prove beneficial to directly reduce PDAC and HCC growth (Falasca et al., 2011).